Incyte to Report Third Quarter Financial Results
October 11 2022 - 8:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
third quarter financial results conference call and webcast for
8:00 a.m. ET on Tuesday, November 1, 2022.
The schedule for the press release and conference call/webcast
is as follows:
- Q3 2022 Press Release: November 1, 2022 at 7:00 a.m. ET
- Q3 2022 Conference Call: November 1, 2022 at 8:00 a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13733379
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay
you will need the conference ID number 13733379.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for ninety
days.
About Incyte Incyte is a Wilmington, Delaware-based,
global biopharmaceutical company focused on finding solutions for
serious unmet medical needs through the discovery, development and
commercialization of proprietary therapeutics. For additional
information on Incyte, please visit Incyte.com and follow
@Incyte.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221011005007/en/
Incyte Contacts Media
Catalina Loveman +1 302 498 6171 cloveman@incyte.com
Investors Christine Chiou +1 302 274 4773
cchiou@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2023 to Jul 2024